Funding Renewed for Biotech Center, LSU One of Five Partners
December 05, 2022
The Center for BioModular Multi-Scale Systems, or CBM2, was recently renewed for funding through the National Institutes of Health as a National Biotechnology Resource Center. CBM2’s partners include LSU, the University of Kansas, the University of Kansas Medical Center, University of North Carolina-Chapel Hill, and Wake Forest School of Medicine.
“LSU is one of the national leaders in plastic micro- and nanomanufacturing, which has become more and more important as the technical paradigm in biomedical communities has shifted to Precision Medicine,” said LSU Mechanical Engineering Professor Sunggook Park, a researcher with CBM2. “Precision Medicine requires acquisition of a huge number of genomic data, and thus, it is critical to produce various biosensors and bioanalytic tools in large quantity at low cost. The devices that we are producing in the center provide the ability to analyze circulating biomarkers secured from blood samples that will have an impact in managing a number of diseases such as cancers, stroke, and bacterial infections. Thus, the technology that we are developing in this center can be an important part of LSU’s recent pursuit of the National Cancer Institute designation. Also, the micro- and nanomanufacturing technologies that we are developing in LSU will contribute to the manufacturing sector of Louisiana industries.”
The LSU College of Engineering and its faculty/student researchers are pursuing advances in the biomedical sector across several disciplines, helping fulfill LSU's mission of improving the state’s health outcomes head-on.